Calithera Biosciences Inc
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Market Cap & Net Worth: Calithera Biosciences Inc (CALA)
Calithera Biosciences Inc (PINK:CALA) has a market capitalization of $2.92K ($2.92K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47688 globally and #14714 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Calithera Biosciences Inc's stock price $0.00 by its total outstanding shares 4872497 (4.87 Million).
Calithera Biosciences Inc Market Cap History: 2015 to 2025
Calithera Biosciences Inc's market capitalization history from 2015 to 2025. Data shows change from $746.47 Million to $2.92K (-73.12% CAGR).
Calithera Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Calithera Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.65x
Calithera Biosciences Inc's market cap is 6.65 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $813.71 Million | $25.95 Million | -$27.83 Million | 31.35x | N/A |
| 2018 | $390.77 Million | $22.25 Million | -$51.47 Million | 17.56x | N/A |
| 2021 | $64.82 Million | $9.75 Million | -$115.09 Million | 6.65x | N/A |
Competitor Companies of CALA by Market Capitalization
Companies near Calithera Biosciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Calithera Biosciences Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Calithera Biosciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Calithera Biosciences Inc's market cap moved from $746.47 Million to $ 2.92K, with a yearly change of -73.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.92K | -92.21% |
| 2024 | $37.52K | -74.33% |
| 2023 | $146.17K | -99.08% |
| 2022 | $15.88 Million | -75.50% |
| 2021 | $64.82 Million | -86.45% |
| 2020 | $478.48 Million | -14.01% |
| 2019 | $556.44 Million | +42.39% |
| 2018 | $390.77 Million | -51.98% |
| 2017 | $813.71 Million | +156.92% |
| 2016 | $316.71 Million | -57.57% |
| 2015 | $746.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Calithera Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.92K USD |
| MoneyControl | $2.92K USD |
| MarketWatch | $2.92K USD |
| marketcap.company | $2.92K USD |
| Reuters | $2.92K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.